Graeme Clark Collection

Permanent URI for this collection

Search Results

Now showing 1 - 3 of 3
  • Item
    Thumbnail Image
    The spectral maxima sound processor: recent findings in speech perception and psychophysics
    McKay, Colette M. ; McDermott, Hugh J. ; Vandali, Andrew E. ; Clark, Graeme M. (Wien, 1994)
    The Spectral Maxima Sound Processor (SMSP) was developed at the University of Melbourne for use with the Mini System 22 implant manufactured by Cochlear Pty Ltd. The SMSP has been shown in recent studies to provide improved speech perception to implantees when compared to the currently commercially available processor for this implant (the MSP (MULTIPEAK) processor). In the first of three experiments, the effect on speech perception of increasing the rate of stimulation of the SMSP and of increasing the number of electrodes activated in each stimulation cycle was studied. It was found that these parameter changes made little difference to speech perception in quiet but both changes were advantageous for some subjects when listening in noise. The second and third experiments investigated psychophysically the effects of two aspects of the SMSP strategy which differ from previous processors for this implant. In the second experiment, it was found that concurrent stimulation of two adjacent or nearby electrodes evoked a pitch which was intermediate to that of either electrode. This may explain, in part, the better discrimination of vowel formants by users of the SMSP. In the third experiment, it was found that a pitch related to the modulation frequency was evoked by amplitude-modulating a constant rate stimulus, provided that the rate of stimulation was sufficiently high (four times the modulation frequency) or a multiple of the modulation frequency. This result may explain the equal ability of SMSP and MSP users to perceive speaker differences and intonation patterns, even though the rate of stimulation is constant In the SMSP.
  • Item
    Thumbnail Image
    Speech processing for cochlear implants
    Tong, Y. C. ; Millar, J. B. ; Blamey, P. J. ; Clark, Graeme M. ; Dowell, R. C. ; Patrick, J. F. ; Seligman, P. M. (JAI Press Ltd, 1992)
    The cochlear implant is a hearing prosthesis designed to replace the function of the ear. The operation of the prosthesis can be described as a sequence of four functions: the processing of the acoustic signal received by a microphone; the transfer of the processed signal through the skin; the creation of neural activity in the auditory nerve; and the integration of the experience of this neural activity into the perceptual and cognitive processing of the implantee.
  • Item
    Thumbnail Image
    Preliminary speech perception results for children with the 22-electrode Melbourne/ cochlear hearing prosthesis
    Cowan, R. S. C. ; Dowell, R. C. ; Pyman, B. C. ; Dettman, S. J. ; Dawson, P. W. ; Rance, G. ; Barker, E. J. ; Sarant, J. Z. ; Clark, Graeme M. ( 1993)
    The 22-electroce cochlear prosthesis developed by the University of Melbourne and Cochlear Pty. Ltd. has been shown to provide significant speech perception benefits to profoundly deafened adults. More recently, use of an improved Multipeak encoding strategy has significantly improved speech perception performance both in quiet and in noise. Benefits to speech perception in children have not as yet been fully documented, in part due to the shorter history of implant use in children and the smaller overall number of children implanted as compared with adults. The first implantation of the 22-electrode cochlear prosthesis in a child was carried out in Melbourne in January of 1985. In Melbourne, a 5-year-old child was operated on in April 1986, and a first congenitally deaf child in April 1987. The age of implantation has been progressively reduced, with the first 2-year-old child implanted in Melbourne in 1990. As at January 1992, approximately 1,200 children (under 18 years of age inclusive) have been implanted worldwide with the 22-electrode cochlear prosthesis. Of this number, approximately 50% are under the age of 6 years. The age of the child, aetiology of the hearing loss, age at onset and duration of the hearing loss, education program attended both prior to and subsequent to implantation, and parental motivation to assist in habilitation are all factors which may affect an individual child's development and progress with the device. Evaluation of performance in children is complicated by a number of issues, including the effects of delayed speech and language development, and the ability of individual children to perform auditory tests. The measure of performance chosen for any evaluation will also reflect the interests of the particular clinician. For example, effects of device use on speech production may be of interest to the speech therapist, whereas educational progress will be of primary importance to the teacher of an implanted child. However, in choosing an appropriate evaluation test to measure progress woth the cochlear prosthesis, it is vital to realize that all measures such as effects of device use on speech production, educational progress, development of language, and effects on social and communication skills depend on the child being able to accurately perceive speech information through her/his device.